Claes Lindblad
Director of Finance/CFO at MODUS THERAPEUTICS HOLDING AB
Profile
Claes Lindblad is currently the Chief Financial Officer at Modus Therapeutics Holding AB since 2021.
Prior to this, he worked as the Chief Financial Officer & Secretary at OssDsign AB from 2016 to 2020.
He also worked as the Manager-National Sales at Nycomed AB from 2009 to 2012 and as a Director at ConvaTec (Sweden) AB.
Mr. Lindblad has a graduate degree from Karlstad University and an MBA from Edinburgh Business School.
Claes Lindblad active positions
Companies | Position | Start |
---|---|---|
MODUS THERAPEUTICS HOLDING AB | Director of Finance/CFO | 2021-03-14 |
Former positions of Claes Lindblad
Companies | Position | End |
---|---|---|
OSSDSIGN AB | Director of Finance/CFO | 2019-12-31 |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Sales & Marketing | 2012-06-30 |
ConvaTec (Sweden) AB | Director/Board Member | - |
Training of Claes Lindblad
Karlstad University | Graduate Degree |
Edinburgh Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OSSDSIGN AB | Health Technology |
MODUS THERAPEUTICS HOLDING AB | Health Technology |
Private companies | 2 |
---|---|
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Health Technology |
ConvaTec (Sweden) AB |
- Stock Market
- Insiders
- Claes Lindblad